Inecalcitol

CAS No.

163217-09-2

MDL No.

N/A

C₂₆H₄₀O₃

400.60

InChI Key

HHGRMHMXKPQNGF-WNSNRMDMSA-N

Pack Size	Purity	Price	Availability
1 mg	To Be Confirmed	$81	In Stock
5 mg	To Be Confirmed	$194	In Stock
10 mg	To Be Confirmed	$330	In Stock
25 mg	To Be Confirmed	$748	In Stock
Custom synthesis and bulk supply options are available upon request.

Pack Size

Purity

Price

Availability

Action

1 mg

To Be Confirmed

$81

In Stock

5 mg

To Be Confirmed

$194

In Stock

10 mg

To Be Confirmed

$330

In Stock

25 mg

To Be Confirmed

$748

In Stock

Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.	163217-09-2
Product Name	Inecalcitol

Biological Targets

VDR

Associated Conditions

chronic myelogenous leukemia·acute myeloid leukemia

* The information provided here is compiled from public sources and is for reference only.

Pricing & Availability

Product Information

Biological Profile

Properties

Biological Targets

Associated Conditions

Documentation

Inecalcitol

Pricing & Availability

Product Information

Biological Profile

Properties

Biological Targets

Associated Conditions

Related Articles

Phase I safety and pharmacodynamic of inecalcitol, a novel VDR agonist with docetaxel in metastatic castration-resistant prostate cancer patients.

Inecalcitol, an analog of 1α,25(OH)(2) D(3) , induces growth arrest of androgen-dependent prostate cancer cells.

Vitamin D derivatives acutely reduce endothelium-dependent contractions in the aorta of the spontaneously hypertensive rat.

Altered Vitamin D receptor-coactivator interactions reflect superagonism of Vitamin D analogs.

Documentation

Similar Products

Paricalcitol